A biomarker study to investigate whther KL-6 levels correlate with response to pirfenidone in patients with idiopathic pulmonary fibrosis.
Phase of Trial: Phase IV
Latest Information Update: 19 Aug 2015
At a glance
- Drugs Pirfenidone (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Biomarker; Therapeutic Use
- 19 Aug 2015 New trial record